The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sacituzumab tirumotecan (sac-TMT) plus pembrolizumab (P) versus pembrolizumab (P) as first-line treatment for PD-L1–positive advanced non-small cell lung cancer (NSCLC): Results from the randomized phase 3 OptiTROP-Lung05 study.
 
Caicun Zhou
Leadership - IASLC BOD
Honoraria - Akeso Biopharma; Alice; Amoy Diagnostics; Anheart Therapeutics; Hengrui Therapeutics; Innovent Biologics; Lilly; Luye Pharma; Merck Sharpe and Dohme; MSD; QiLu Pharmaceutical; Sanofi; TopAlliance BioSciences Inc
Consulting or Advisory Role - Amoy Diagnostics; Hengrui Therapeutics; Innovent Biologics; QiLu Pharmaceutical; Top Alliance BioScience
 
Anwen Xiong
No Relationships to Disclose
 
Wenxiu Yao
No Relationships to Disclose
 
Wei Zheng
No Relationships to Disclose
 
Yan Yu
No Relationships to Disclose
 
Peng Chen
No Relationships to Disclose
 
Hua Zhong
No Relationships to Disclose
 
Hui Wang
No Relationships to Disclose
 
Bolin Chen
No Relationships to Disclose
 
Haiyong Wang
No Relationships to Disclose
 
Yun Fan
No Relationships to Disclose
 
Yunpeng Yang
No Relationships to Disclose
 
Xingxiang Pu
No Relationships to Disclose
 
Qiming Wang
No Relationships to Disclose
 
Xia Song
No Relationships to Disclose
 
Zhangzhou Huang
No Relationships to Disclose
 
Xiao-bo Du
No Relationships to Disclose
 
Yan Qing
No Relationships to Disclose
 
Xiaoping Jin
No Relationships to Disclose
 
Junyou Ge
Employment - Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Leadership - Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Stock and Other Ownership Interests - Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Travel, Accommodations, Expenses - Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.